Top Links

Articles Related to Esophageal Cancer

Prevention and Treatment of Esophageal Cancer in China: Achievements and Challenges-Prevention is the Key

Background: The study investigated esophageal cancer etiology and pathology, along with problems associated with surgical treatments. Keywords: Esophageal cancer; Mortality; Etiology; Pathology; Treatment; 5-year survivalIntroduction Methods: Data from the National Cancer Prevention and Control Office and the National Cancer Registry Center (2012) were assessed for information regarding malignant tumor incidence. These data were also used to conduct a mortality analysis and investigate death records pertaining to esophageal cancer patients. We extracted crude and age-specific mortality data and proportional mortality ratios as well as standard mortality data for Chinese and world populations. Esophageal cancer mortality was compared with death statistical data and literature related to esophageal cancer was collected from the Chinese Biomedical Literature Database and the Chinese Journal Network.
View complete article: PDF  |  Full-text

Effect of Neoadjuvant Chemoradiotherapy on Pathologic Stage and Survival in Patients with Locally Advanced Esophageal Cancer

The treatment of resectable stages of esophageal cancer often involves pre-operative concurrent chemoradiotherapy. This study aims to evaluate the effect of cisplatin/5-fluorouracil (5-FU)-based neoadjuvant chemoradiotherapy on pathologic stage and survival in patients with locally advanced esophageal cancer.
View complete article: PDF  |  Full-text

Gastroesophageal Cancer: Prognostic Factors and Treatment Results

The study presents the remote results of surgical treatment of 329 patients with cancer of gastroesophageal localization. Three 3-year survival rate is 37.1%, the 5-year survival rate is 26.2%. Prognosis after the surgery depends primarily on the extent of the tumour spread.
View complete article: PDF  |  Full-text

Esophageal Cancer and Bisphosphonates

At the beginning of 2009, Dianne Wysowski of the US Food and Drug Administration summarized 23 reports of esophageal1 cancer following alendronate use. Wysowski also noted that there had been 31 cases following alendronate use in Europe and Japan and ten cases in which other bisphosphonates had been reported as concomitant or suspect treatment.
View complete article: PDF  |  Full-text


Editorial Board Members Related to Esophageal Cancer

Jimmy SO

Associate Professor
Department of Surgery
Yong Loo Lin School of Medicine
National University Health System
Singapore

MING-JEN CHEN

Assistant Professor
Division of Gastroenterology
Department of Internal Medicine
Mackay Medical College
Taiwan

Michael Gibson

Associate Professor
Department of Medicine
Case Western Reserve University
United States

Xiaoqing Guo

Division of Genetic and Molecular Toxicology
National Center for Toxicological Research (NCTR)
USA
Submit Manuscript


Open Access Journals

View All Journals